Team

Oliver Szolar | PhD

CEO

SPh_Oliver-Szolar

Oliver Szolar has worked in research and the pharmaceutical industry for 14 years. Previously, he held the position of the CSO at onepharm. Prior to that, he was head of analytical operations at onepharm and Aphton/Igeneon, Austria, after heading the instrumental analysis at the IFA, Department for Environmental Biotechnology, Austria. He holds a PhD in biotechnology from the University of Natural Resources and Life Sciences, Vienna, Austria.

Helmut H. Buschmann | PhD

CSO

SPh_Helmut-Buschmann_b

Helmut H. Buschmann is a senior management executive with 19 years of international experience in drug discovery research and drug development in the pharmaceutical and biotechnology industry. Helmut Buschmann spent 10 years with Grünenthal (Aachen) before joining Laboratorios Dr. Esteve in Barcelona as research director for 7 years. In 2009, he joined Pharma Consulting Aachen as independent consultant for diverse companies. Under his guidance, more than 15 NCEs entered clinical development with some of them reaching clinical phase III and the market (e.g. Tapentadol marketed as Nucynta® in the U.S. and as Palexia® in Europe). Helmut Buschmann led or co-authored more than 90 publications in the field, edited and authored three books, and is listed as inventor in more than 180 patent applications. Moreover, he is member of several scientific advisory boards of public research institutions in Europe and gives lectures at the universities of Aachen and Rostock.

Andrea Wolkerstorfer | PhD

Head Virology

SPh_Andrea-Wolkerstorfer

Andrea Wolkerstorfer was previously head of molecular biology at onepharm. She graduated from the Research Institute of Virology and Biomedicine, University of Veterinary Medicine, Vienna, Austria, and the University of Natural Resources and Life Sciences, Vienna, Austria, working on retroviral vector systems for the analysis of putative tissue/tumor-specific promoters in vitro and in vivo and the possible role of M-gene products on immunogenicity of influenza A reassortants. Andrea also holds a MSc Medical Diagnostics from Cranfield University at Silsoe, Bedfordshire/UK, and has experience in GLP.

Klaus Kurth | Mag

Head Finance

SPh_Klaus-Kurth_b

Klaus Kurth has started his professional career as a financial analyst for the Erste Bank in the Asset Liability Management division in Vienna. As an expatriate finance manager he then transferred to an international semiconductor manufacturer located in the Silicon Valley, California. He has held finance and management positions in the Austrian retail sector with the Management Trust Holding and the Austrian IT sector with Microsoft. Graduating from Austria’s University of Vienna, he holds a master’s degree in International Business Administration majoring in Corporate Finance as well as an executive degree from the Harvard Business School.